Arkolith/Insider Trading/ACRX/Form 4

Angotti Vincent J.

Chief Executive Officer, DirectorACELRX PHARMACEUTICALS INC (ACRX) · full profile →Form 4 · filed Feb 14, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 11, 2022Tax withholding(F)23K$0.40$9K984K
Feb 11, 2022Grant(A)390K—$01.0M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 11, 2022Grant(A)780K—$0780K

Transaction Codes

F
Shares withheld for taxes
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-009343) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML